Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.06
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.67 +8.10%
Financial Fact:
Operating income: -813K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income: -813K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.06, versus $0.08 reported last year. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.1 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
